Partner Content Women in AI - an evening of practical AI learning Women in AI returns November 10 in London, UK. Join women from across healthcare for an evening of practical AI learning.
Digital Controlling AI hallucinations: Building evidence-based trust... When it comes to GenAI, industry must demand evidence-grounded systems that prioritise verifiable clinical data and rigorous human oversight.
Sales & Marketing Commercial teams are running yesterday's plays. AI just chan... What leading companies are building now is fundamentally different: decision systems.
Market Access Is AI the missing link in fixing MLR – or the reason it brea... Somewhere in a shared drive at a mid-size pharma company, there is a folder labelled “Q3 Messaging FINAL v3 (2).” Inside it are three Word documents with tracked changes from four people, n
Digital How GenAI is cracking the toughest targets in drug discovery Generative AI has the potential to solve for designing effective antibodies for G‑protein coupled receptors (GPCRs).
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.